Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis.
Gut(2023)
摘要
Novel biomarkers, including IL-6, uNGAL and copeptin, can probably improve prognostication of patients with decompensated cirrhosis compared with MELD alone.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要